|
|
Article: AEterna signs an agreement with LG Life Sciences for marketing Neovastat(TM) in Korea; (x) All amounts are in Canadian dollars.
- Article from:
- PR Newswire
- Article date:
- March 26, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
AEterna Laboratories Inc. (TSX: AEL; NASDAQ: AELA) today announced it has signed an agreement with Korean based LG Life Sciences Ltd. , an affiliate of the LG Group for marketing Neovastat in Korea. The agreement provides AEterna with upfront and milestone payments, as well as a return on manufacturing and sales of Neovastat. Together with earlier agreements with Medac GmbH of Germany, Grupo Ferrer Internacional of Spain and Mayne Pharma of Australia, the partnership with LG Life Sciences Ltd. extends AEterna's coverage for Neovastat to nearly 50% of the oncology world market and allows the Company to surpass the $50 million mark in milestone payments.
"This new ...
Related newspaper, magazine, and journal articles:
|